标题
Hormone response in ovarian cancer: time to reconsider as a clinical target?
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 19, Issue 6, Pages R255-R279
出版商
Bioscientifica
发表日期
2012-10-09
DOI
10.1530/erc-12-0175
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression
- (2012) Jing Zhu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Ovarian Cancer
- (2012) Francesmary Modugno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition
- (2011) K K Tsilidis et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
- (2011) Ilaria De Stefano et al. GYNECOLOGIC ONCOLOGY
- Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
- (2011) Ahmed Elattar et al. GYNECOLOGIC ONCOLOGY
- Distinct Expression Pattern of Dicer1 Correlates with Ovarian-Derived Steroid Hormone Receptor Expression in Human Fallopian Tubes during Ovulation and the Midsecretory Phase
- (2011) Ruijin Shao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
- (2011) Linda E Kelemen et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium
- (2011) Galina Lurie et al. PLoS One
- Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer
- (2011) Martin Ligr et al. PLoS One
- Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study
- (2010) M. G. M. Braem et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Fertility drugs and ovarian cancer risk: a critical review of the literature
- (2010) Nikos F. Vlahos et al. Annals of the New York Academy of Sciences
- Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal
- (2010) Richard J. Zaino et al. CANCER
- Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth
- (2010) Jung-Hye Choi et al. CARCINOGENESIS
- 17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer
- (2010) Laura A. Laviolette et al. ENDOCRINOLOGY
- Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
- (2010) Jean A. Hurteau et al. GYNECOLOGIC ONCOLOGY
- Tubal ligation and the risk of ovarian cancer: review and meta-analysis
- (2010) D. Cibula et al. HUMAN REPRODUCTION UPDATE
- Expressions of Estrogen and Progesterone Receptors in Epithelial Ovarian Cancer
- (2010) Siriwan Tangjitgamol et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hormonal Regulation and Distinct Functions of Semaphorin-3B and Semaphorin-3F in Ovarian Cancer
- (2010) D. Joseph et al. MOLECULAR CANCER THERAPEUTICS
- Estrogen Receptor Subtypes in Ovarian Cancer
- (2010) Karen K. L. Chan et al. OBSTETRICS AND GYNECOLOGY
- Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events
- (2010) Nathan J. Charles et al. Hormones & Cancer
- Androgen-related expression of G-proteins in ovarian cancer
- (2009) L A Sheach et al. BRITISH JOURNAL OF CANCER
- Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin
- (2009) Celeste Leigh Pearce et al. CANCER
- Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma
- (2009) Lois M. Ramondetta et al. CANCER
- The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor for Degradation in Breast Cancer Cells
- (2009) X. Wu et al. CANCER RESEARCH
- Hormone therapy for epithelial ovarian cancer
- (2009) Simon P Langdon et al. CURRENT OPINION IN ONCOLOGY
- Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome
- (2009) Agnieszka Honorata Ludwig et al. ENDOCRINE-RELATED CANCER
- Progesterone Receptor Membrane Component-1 Regulates the Development and Cisplatin Sensitivity of Human Ovarian Tumors in Athymic Nude Mice
- (2009) John J. Peluso et al. ENDOCRINOLOGY
- Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)
- (2009) Louise A. Brinton et al. FERTILITY AND STERILITY
- Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells
- (2009) Akira Takahashi et al. GYNECOLOGIC ONCOLOGY
- A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
- (2009) Peter A. Argenta et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study
- (2009) Thomas F. Rocereto et al. GYNECOLOGIC ONCOLOGY
- The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women
- (2009) Kim N. Danforth et al. INTERNATIONAL JOURNAL OF CANCER
- Attenuated Sex Steroid Receptor Expression in Fallopian Tube of Women with Ectopic Pregnancy
- (2009) Andrew W. Horne et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
- (2008) C L Pearce et al. BRITISH JOURNAL OF CANCER
- Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma
- (2008) Fumihiko Suzuki et al. CANCER SCIENCE
- Epithelial ovarian cancer: testing the 'androgens hypothesis'
- (2008) C. M Olsen et al. ENDOCRINE-RELATED CANCER
- Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview
- (2008) Wai-Kin So et al. FEBS Journal
- The relationship of endometriosis and ovarian malignancy: a review
- (2008) Farr Nezhat et al. FERTILITY AND STERILITY
- Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory
- (2008) Zeina Nahleh Future Oncology
- Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts
- (2008) William J. Murdoch et al. GYNECOLOGIC ONCOLOGY
- Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum
- (2008) Pedro T. Ramirez et al. GYNECOLOGIC ONCOLOGY
- Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors
- (2008) Marisa Romero-Sánchez et al. HUMAN PATHOLOGY
- Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1
- (2008) John J. Peluso et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Steroid-converting enzymes in human ovarian carcinomas
- (2008) Justin C. Chura et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Activity of Medroxyprogesterone Acetate, an Androgenic Ligand, in Ovarian Cancer Cell Invasion
- (2008) Radhika Gogoi et al. Reproductive Sciences
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search